ACFMarketWrap: A $63bn AI financing deal is firing up chip stocks as falling oil prices give Wall Street another lift ahead of the Fed - US equities mostly advanced Tuesday as semiconductor gains, easing energy costs and mixed corporate earnings kept investors engaged ahead of Wednesday's crucial interest-rate decision.
The S&P 500 gained 0.3%, Nasdaq 100 climbed 0.7% and Dow held near flat. $AVGO surged over 4% after a banking consortium and $BX announced $63bn in financing linked to Anthropic's use of Broadcom technology, reinforcing confidence in large-scale AI infrastructure spending. Earnings delivered sharp contrasts: $JBLU soared 12% on an upbeat margin outlook, while $UPS gained 2% after beating profit expectations.
However, $BA ▼9% after reporting a larger-than-expected 3Q26 loss, and $GLW ▼4% despite stronger-than-forecast results. $WHR ▼over 1% following a quarterly loss, while $PYPL ▼ 0.5% after 3Q26 revenue disappointed. Attention now turns to the Fed, with rates widely expected to remain unchanged as investors scrutinise policymakers' guidance for signs of further tightening before year-end.
Mag 7 mixed: $GOOG +1.08%, $NVDA +0.91%, $MSFT -0.01%, $AMZN +1.79%, $TSLA +3.63%, $META -1.01%, $AAPL +0.65%.
Europe extended its recovery for a second session as declining oil prices improved the inflation outlook amid renewed diplomatic efforts to resolve the US-Iran conflict.
The Euro STOXX 50 +0.8% and STOXX 600 +0.5%, with Italy +0.8%, Germany and Spain +0.7%, and France +0.4%, while the UK bucked the trend with a 0.7%▼. Mining and technology stocks led the advance, while personal care and automakers lagged.
Corporate results remained a major source of volatility: $HSBA ▼5.4% after 3Q26 profits missed expectations, while $RKT ▼4.9% after cutting its sales outlook amid US supply constraints and weaker vitamin demand in China. $P911 gained 3.8% as resilient profitability helped offset declining vehicle deliveries.
UK bucked the trend. Mining and technology stocks led the continental advance, while personal care and automakers lagged. London faced a tougher session, with the FTSE 100 ▼ > 0.5% as disappointing earnings and weaker energy shares overshadowed a mining rally.
Oil majors also struggled as Brent retreated on renewed US-Iran peace hopes, sending $SHEL.L▼1.7% and $BP.L ▼2.8%. Miners provided a rare bright spot, with $ANTO.L + 4.6%, while $EDV.L, $FRES.L and $RIO.L + ~2.5% each and $AAL.L +2.3%. UK inflation pressures also resurfaced as October shop price inflation accelerated to 2.1% y/y from 1.4% in September, exceeding the 1.6% forecast and complicating the outlook for consumer spending and monetary policy.
Next in focus: API Crude Oil Stock Change. ACFview
@WizardBattery @EU_Startups @Share_Talk @ZaksTradersCafe @zakmir @VOXmarkets @focusIR @LondonSouthEast @BullsNBearsWA @ArthurBenta
ACF Equity Research retweeted
Cleantech capital is abundant; proof is not. Currence: $26.1bn in 1H26 funding, but deals fell 25%; low-carbon data centres took 34%. ACF view: be selective in 2026. Solar and battery deals need contracted revenue and IP ownership; e-fuels and new storage still face scale-up risk.
$FSLR $ORSTED $ENS $LIN $NESTE $SLB $UMI $RR $SU $CARR
Read #ACFThematicResearch bit.ly/Cleantech-FutureTechn…
@FirstSolar @Orsted @EnerSys @Lindeplc @NesteGlobal @UmicoreGroup @RollsRoyce @SchneiderElec @CarrierGlobal @Vestas @Novonesis @airliquidegroup @BakerHughesCo @enphaseenergy
@WizardBattery @EU_Startups @Share_Talk @ZaksTradersCafe @zakmir @VOXmarkets @focusIR @LondonSouthEast @BullsNBearsWA @ArthurBenta
ACF Equity Research retweeted
ACFMorningMeeting - Europe sneezes? - A semiconductor rally lifted Asian shares, but European futures turned lower ahead of the Fed, the UK Budget and large-company results. HSBC's profit growth and Novartis's guidance upgrade show that investors still have company-specific earnings to weigh against the weaker opening call.
Opens - FTSE 100 futures were 10,736.5 -0.58%, EURO STOXX 50 futures 6,098 -0.61% and DAX futures 25,443.5 -0.43%; CAC 40 futures were 7,829 -0.45%. US futures: Dow +0.07%, S&P 500 -0.10%, Nasdaq 100 -0.43%. Earlier Asian cash markets: Nikkei +2.2%, Kospi +3.6%, Hang Seng -0.2%, Shanghai -0.1%. $STOXX $FTSE $FTMC $DAX $CAC $DJI $GSPC $IXIC
Stock Watch - HSBC $HSBA.L reported 3Q PBT of $9.63bn +32%, but much of the reported increase reflected the non-recurrence of a prior-year legal provision; it announced a further buyback of up to $1bn. Novartis $NOVN.SW lifted its YE26E core operating-income outlook after 3Q core operating income rose +10% at constant currency, while reported net income fell -70% after a pipeline impairment.
Commods - Brent c.$115.96/bbl, WTI c.$101.68/bbl, GOLD c.$4,004/toz -0.31% and COPPER c.$6.51/lb (broadly flat). COCOA $5,490/MT -1.82%, with no new driver verified; SUGAR raw benchmark CFD 19.10¢/lb -5.63% as lower oil, a weaker Brazilian real and resumed crushing impacted pricing; COFFEE Arabica-linked benchmark 300.95¢/lb -2.11% as a weaker real and improved supply expectations influenced expectations.
Data Focus - The Fed meeting begins today. US durable-goods orders and consumer confidence are also due today; the UK Budget and Fed decision follow Wednesday, with the ECB decision Thursday.
ACFView: We still prefer EPS with clear correlations with cash generation over a broad semiconductor rally until European shares and bond yields confirm there is solid appetite for risk.
@WizardBattery @EU_Startups @Share_Talk @ZaksTradersCafe @zakmir @VOXmarkets @focusIR
@LondonSouthEast @BullsNBearsWA @ArthurBenta
@aimrns
Healthcare - Novartis $NOVN.SW raised YE26E core operating-income guidance after 3Q sales +4% and core operating income +10%. Reported net income fell -70% after a pipeline impairment. ACFView: In big pharma we favour actual drug sales, with cash and pipeline risk in view.
ACFMorningMeeting - Europe sneezes? - A semiconductor rally lifted Asian shares, but European futures turned lower ahead of the Fed, the UK Budget and large-company results. HSBC's profit growth and Novartis's guidance upgrade show that investors still have company-specific earnings to weigh against the weaker opening call.
Opens - FTSE 100 futures were 10,736.5 -0.58%, EURO STOXX 50 futures 6,098 -0.61% and DAX futures 25,443.5 -0.43%; CAC 40 futures were 7,829 -0.45%. US futures: Dow +0.07%, S&P 500 -0.10%, Nasdaq 100 -0.43%. Earlier Asian cash markets: Nikkei +2.2%, Kospi +3.6%, Hang Seng -0.2%, Shanghai -0.1%. $STOXX $FTSE $FTMC $DAX $CAC $DJI $GSPC $IXIC
Stock Watch - HSBC $HSBA.L reported 3Q PBT of $9.63bn +32%, but much of the reported increase reflected the non-recurrence of a prior-year legal provision; it announced a further buyback of up to $1bn. Novartis $NOVN.SW lifted its YE26E core operating-income outlook after 3Q core operating income rose +10% at constant currency, while reported net income fell -70% after a pipeline impairment.
Commods - Brent c.$115.96/bbl, WTI c.$101.68/bbl, GOLD c.$4,004/toz -0.31% and COPPER c.$6.51/lb (broadly flat). COCOA $5,490/MT -1.82%, with no new driver verified; SUGAR raw benchmark CFD 19.10¢/lb -5.63% as lower oil, a weaker Brazilian real and resumed crushing impacted pricing; COFFEE Arabica-linked benchmark 300.95¢/lb -2.11% as a weaker real and improved supply expectations influenced expectations.
Data Focus - The Fed meeting begins today. US durable-goods orders and consumer confidence are also due today; the UK Budget and Fed decision follow Wednesday, with the ECB decision Thursday.
ACFView: We still prefer EPS with clear correlations with cash generation over a broad semiconductor rally until European shares and bond yields confirm there is solid appetite for risk.
@WizardBattery @EU_Startups @Share_Talk @ZaksTradersCafe @zakmir @VOXmarkets @focusIR
@LondonSouthEast @BullsNBearsWA @ArthurBenta
@aimrns
ACF Equity Research retweeted
Gold - c.$4,004/toz (-0.31%) as $ strengthened ahead of the Fed. ACFView: retain bullion, wait for dollar and real yields before adding tactically. Note for listed miners, cash generation depends on realised prices over time, product and unit costs. Of interest is @Skylark_ASX
Listen to ASX-listed @Skylark_ASX MD Michael Jardine talk about Skylark’s massive new gold resource upgrade that still has plenty of legs left in it.
3aw.com.au/skylark-minerals-…
$SKM #BullsNBearsWA @3AW693 #ASX
ACF Equity Research retweeted
ACFMorningMeeting Shorts - Asia's chip rally has not carried into European futures. Novartis $NOVN.SW raised its YE26E core profit outlook; HSBC $HSBA.L's headline PBT gain includes a favourable comparison. ACFView: back delivered earnings, not the index bounce.
ACFMorningMeeting - Europe sneezes? - A semiconductor rally lifted Asian shares, but European futures turned lower ahead of the Fed, the UK Budget and large-company results. HSBC's profit growth and Novartis's guidance upgrade show that investors still have company-specific earnings to weigh against the weaker opening call.
Opens - FTSE 100 futures were 10,736.5 -0.58%, EURO STOXX 50 futures 6,098 -0.61% and DAX futures 25,443.5 -0.43%; CAC 40 futures were 7,829 -0.45%. US futures: Dow +0.07%, S&P 500 -0.10%, Nasdaq 100 -0.43%. Earlier Asian cash markets: Nikkei +2.2%, Kospi +3.6%, Hang Seng -0.2%, Shanghai -0.1%. $STOXX $FTSE $FTMC $DAX $CAC $DJI $GSPC $IXIC
Stock Watch - HSBC $HSBA.L reported 3Q PBT of $9.63bn +32%, but much of the reported increase reflected the non-recurrence of a prior-year legal provision; it announced a further buyback of up to $1bn. Novartis $NOVN.SW lifted its YE26E core operating-income outlook after 3Q core operating income rose +10% at constant currency, while reported net income fell -70% after a pipeline impairment.
Commods - Brent c.$115.96/bbl, WTI c.$101.68/bbl, GOLD c.$4,004/toz -0.31% and COPPER c.$6.51/lb (broadly flat). COCOA $5,490/MT -1.82%, with no new driver verified; SUGAR raw benchmark CFD 19.10¢/lb -5.63% as lower oil, a weaker Brazilian real and resumed crushing impacted pricing; COFFEE Arabica-linked benchmark 300.95¢/lb -2.11% as a weaker real and improved supply expectations influenced expectations.
Data Focus - The Fed meeting begins today. US durable-goods orders and consumer confidence are also due today; the UK Budget and Fed decision follow Wednesday, with the ECB decision Thursday.
ACFView: We still prefer EPS with clear correlations with cash generation over a broad semiconductor rally until European shares and bond yields confirm there is solid appetite for risk.
@WizardBattery @EU_Startups @Share_Talk @ZaksTradersCafe @zakmir @VOXmarkets @focusIR
@LondonSouthEast @BullsNBearsWA @ArthurBenta
@aimrns
ACFMorningMeeting - Europe sneezes? - A semiconductor rally lifted Asian shares, but European futures turned lower ahead of the Fed, the UK Budget and large-company results. HSBC's profit growth and Novartis's guidance upgrade show that investors still have company-specific earnings to weigh against the weaker opening call.
Opens - FTSE 100 futures were 10,736.5 -0.58%, EURO STOXX 50 futures 6,098 -0.61% and DAX futures 25,443.5 -0.43%; CAC 40 futures were 7,829 -0.45%. US futures: Dow +0.07%, S&P 500 -0.10%, Nasdaq 100 -0.43%. Earlier Asian cash markets: Nikkei +2.2%, Kospi +3.6%, Hang Seng -0.2%, Shanghai -0.1%. $STOXX $FTSE $FTMC $DAX $CAC $DJI $GSPC $IXIC
Stock Watch - HSBC $HSBA.L reported 3Q PBT of $9.63bn +32%, but much of the reported increase reflected the non-recurrence of a prior-year legal provision; it announced a further buyback of up to $1bn. Novartis $NOVN.SW lifted its YE26E core operating-income outlook after 3Q core operating income rose +10% at constant currency, while reported net income fell -70% after a pipeline impairment.
Commods - Brent c.$115.96/bbl, WTI c.$101.68/bbl, GOLD c.$4,004/toz -0.31% and COPPER c.$6.51/lb (broadly flat). COCOA $5,490/MT -1.82%, with no new driver verified; SUGAR raw benchmark CFD 19.10¢/lb -5.63% as lower oil, a weaker Brazilian real and resumed crushing impacted pricing; COFFEE Arabica-linked benchmark 300.95¢/lb -2.11% as a weaker real and improved supply expectations influenced expectations.
Data Focus - The Fed meeting begins today. US durable-goods orders and consumer confidence are also due today; the UK Budget and Fed decision follow Wednesday, with the ECB decision Thursday.
ACFView: We still prefer EPS with clear correlations with cash generation over a broad semiconductor rally until European shares and bond yields confirm there is solid appetite for risk.
@WizardBattery @EU_Startups @Share_Talk @ZaksTradersCafe @zakmir @VOXmarkets @focusIR
@LondonSouthEast @BullsNBearsWA @ArthurBenta
@aimrns
ACF Equity Research retweeted
Replying to @azitrainc
@azitrainc results from ex vivo ATR COSF study
*2 cosmetic models evaluated
*Visible improvements in fine lines, wrinkles & elasticity after 1 dose
*Continued improvement observed up to 48 hrs
*30 subject study results by year end
*Further details @ BIO-Europe 9-11Nov
$AZTR
https:/tinyurl.com/mayfd33z
ACF Equity Research retweeted
Replying to @TuhuraBio
@TuhuraBio first look @ IFx2.0 deep seated Merkel cell carcinoma open label study w/ Keytruda
*Webcast @ 8:30 am ET
*Each of the 3 first patients achieved major objective antitumor response (PR) @ 6 months
*9 patient enrollment goal
$HURA
https:/tinyurl.com/2zwjmakk
ACF Equity Research retweeted
Replying to @Spectral_MDAI
@Spectral_MDAI CEO Vince Capone reviews past studies noting that these relationships help recruit new study sites and demand for the DeepView device.
#DeepViewAI #WoundCare #MedicalAI #AI #HealthTech #MedTech #LifeSciences #Biotech #MedicalDevices #DiagnosticTools
youtube.com/shorts/-UTs7Ays9…
ACF Equity Research retweeted
Listen to ASX-listed @Skylark_ASX MD Michael Jardine talk about Skylark’s massive new gold resource upgrade that still has plenty of legs left in it.
3aw.com.au/skylark-minerals-…
$SKM #BullsNBearsWA @3AW693 #ASX
ACF Equity Research retweeted
#Gold explorer @PLCresources has generated a suite of ranked gold targets at its project near Meekatharra in WA, with some showing spectral signatures similar to a nearby producing gold mine.
$PLC #BULLSNBEARSWA #ASX @brisbanetimes
brisbanetimes.com.au/busines…
ACF Equity Research retweeted
Explorer @Orbit_Resources has unveiled a 1km magnetic target at its Lewis Ponds project in NSW, along strike from Cousin Jack, pointing to the potential for new #sulphide mineralisation.
$OBT #BULLSNBEARSWA #ASX @smh
smh.com.au/business/companie…
ACF Equity Research retweeted
A note on Brazil:
tavicosta.substack.com/p/a-n…
ACF Equity Research retweeted
Nice move in $S from the recent lows!
Cybersecurity + AI tailwinds are coming into play now.
Perfect spot for a nice bounce in $S from support.
After the selling across small and midcap tech, a lot of diamonds in the rough emerged.
This is one that I think has a lot of upside potential
AI + cybersecurity as tailwinds.
ACF Equity Research retweeted
Buying a smart appliance can be a dumb decision.
ACF Equity Research retweeted
Weekend Chart Rundown: 25 October
Zak Mir takes a charting look at FTSE 100, Dax, Dow, Bitcoin, Ethereum, Gold, WTI Crude Oil, Acuity, Critical Metals, Capita, Delta Gold, Energy B, Eurasia, GreenX, Genincode, Gunsynd, Huddled, Hardide, Medpal, Northern Bear, Rockhopper.
voxmarkets.com/articles/vide…
ACF Equity Research retweeted
UK grid bottlenecks force costly curtailment of renewable energy output stockmark.it/britains-renewa…



















